Table 2 Comparison of demographic and clinical characteristics of air injection and control subjects.
From: Effect of intracameral air injection during Ahmed glaucoma valve implantation on hypertensive phase
Control group (n = 57) | Air injection group (n = 21) | P value | |
|---|---|---|---|
Age (years) | 57.6 ± 11.9 | 62.3 ± 14.3 | 0.144~ |
Sex (M/F) | 33(57.9%)/24(42.1%) | 15(71.4%)/6(28.6%) | 0.276* |
Diabetes (Yes/No) | 38(66.7%)/19(33.3%) | 17(81%)/4(19%) | 0.220* |
Phakic / Pseudophakic | 10(17.5%)/47(82.5%) | 7(33.3%)/14(66.7%) | 0.214† |
Subtype of glaucoma | |||
Primary open angle | 2 (3.5%) | 1 (4.8%) | |
Neovascular | 21 (36.8%) | 17 (81.0%) | |
Uveitic | 5 (8.8%) | 1 (4.8%) | |
Pseudoexfoliative | 6 (10.5%) | 0 (0%) | |
Iridocorneal endothelial | 1 (1.8%) | 0 (0%) | |
Pseudophakic | 2 (3.5%) | 0 (0%) | |
Secondary glaucoma following vitreo-retinal surgeries | 19 (33.3%) | 2 (9.5%) | |
Traumatic | 1 (1.8%) | 0 (0%) | |
NVG (Yes/No) | 21(36.8%) /36(63.2%) | 17(81.0%)/4(19.0%) | 0.001* |
Axial length (mm) | 24.35 ± 1.74 | 23.94 ± 1.56 | 0.411~ |
Prior glaucoma surgery (Yes/No) | 17(29.8%)/40(70.2%) | 4(19.0%)/17(81.0%) | 0.341* |
Baseline IOP (mmHg) | 30.7 ± 6.9 | 36.3 ± 8.6 | 0.004~ |
